61 results on '"Ahmed, Hashim U."'
Search Results
2. PD39-01 THE SUITABILITY OF HEMI-ABLATION FOR PATIENTS DIAGNOSED WITH LOCALISED PROSTATE CANCER FOLLOWING MULTIPARAMETRIC MRI TARGETED AND NON-TARGETED TRANSPERINEAL PROSTATE BIOPSY
3. Evaluation of Outcomes following Focal Ablative Therapy for Treatment of Localised Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-year Experience.
4. MP55-08 THE DIAGNOSTIC ACCURACY OF 68 GA-PSMA PET/CT VERSUS MULTIPARAMETRIC MRI FOR LOCALIZING INTRA-PROSTATIC RADIORECURRENT PROSTATE CANCER
5. MP73-04 EXTERNAL VALIDATION OF A RISK SCORE PREDICTING FAILURE AFTER SALVAGE FOCAL THERAPY FOR LOCALIZED RADIORECURRENT PROSTATE CANCER: AN ANALYSIS FROM THE FOCAL RECURRENT ASSESSMENT AND SALVAGE TREATMENT (FORECAST) TRIAL
6. MP44-02 SYSTEMATIC AND MRI-TARGETED BIOPSY STRATEGIES FOR THE DETECTION OF RADIORECURRENT PROSTATE CANCER: AN ANALYSIS FROM THE FOCAL RECURRENT ASSESSMENT AND SALVAGE TREATMENT (FORECAST) TRIAL
7. MP44-06 TUMOR CHARACTERISTICS OF MULTIPARAMETRIC MRI-DETECTED AND -UNDETECTED LESIONS IN PATIENTS WITH SUSPECTED RADIORECURRENT PROSTATE CANCER: AN ANALYSIS FROM THE FOCAL RECURRENT ASSESSMENT AND SALVAGE TREATMENT (FORECAST) TRIAL
8. MP40-03 CIRCULATING CHROMOSOME CONFORMATION SIGNATURES ENHANCE THE ACCURACY OF PSA FOR DETECTING PROSTATE CANCER - RESULTS FROM PERFORMANCE OF THE EPISWITCH TM PCA TEST IN THE PROSTAGRAM TRIAL
9. PD17-01 DERIVATION AND EXTERNAL VALIDATION OF A RAPID RISK SCORE FOR PREDICTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN WITH AN MRI VISIBLE LESION: A MULTINATIONAL COHORT STUDY
10. Clinical and pathologic characteristics to select patients for focal therapy or partial gland ablation of nonmetastatic prostate cancer
11. MP34-16 SWITCHING FROM SEDATION TO LOCAL ANAESTHETIC TRANSPERINEAL PROSTATE BIOPSIES: A COST-BENEFIT ANALYSIS
12. MP05-10 IMPACT OF NON-TARGETED PROSTATE SAMPLING HISTOLOGY ON THE PROBABILITY OF RECEIVING INVASIVE LOCAL TREATMENT IN AN MPMRI-TARGETED PATHWAY—ANALYSIS OF 1,719 MEN
13. PD34-12 MRI FINDINGS IN DE NOVO SYNCHRONOUS METASTATIC PROSTATE CANCER AND IMPLICATIONS FOR CYTOREDUCTIVE SURGERY
14. MP01-07 PRESERVATION OF SEXUAL FUNCTION FOLLOWING REZUM® THERAPY FOR LUTS/BPH TOO GOOD TO BE TRUE? REAL WORLD OUTCOMES FROM 181 CASES
15. MP11-10 RE-REFERRAL RATES IN THE MEDIUM TERM IN PATIENTS WITH A NON-SUSPICIOUS MPMRI WITHIN THE RAPID PATHWAY
16. Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer
17. A Comparison of Prostate Cancer Detection between Visual Estimation (Cognitive Registration) and Image Fusion (Software Registration) Targeted Transperineal Prostate Biopsy
18. Evaluating the Trade-Offs Men with Localized Prostate Cancer Make between the Risks and Benefits of Treatments: The COMPARE Study
19. MP56-11 THE RAPID RISK SCORE
20. PD17-04 IS FOCAL ABLATION AS EFFECTIVE AS HEMI-ABLATION? ANALYSIS OF TREATMENT PATTERNS OVER 12 YEARS FROM A HIGH VOLUME CENTRE FOR FOCAL THERAPY
21. LBA02-01 POPULATION-BASED PROSTATE CANCER SCREENING USING A PROSPECTIVE, BLINDED, PAIRED SCREEN-POSITIVE COMPARISON OF PSA AND FAST MRI: THE IP1-PROSTAGRAM STUDY
22. Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound
23. MP27-10 DIRECT AND MARGINAL COST ANALYSIS OF NOT AIMING FOR THE TARGET IN A MRI-TARGETED PROSTATE BIOPSY PATHWAY
24. Comparison of Transrectal Ultrasound Biopsy to Transperineal Template Mapping Biopsies Stratified by Multiparametric Magnetic Resonance Imaging Score in the PROMIS Trial
25. MP78-10 A COMPARISON OF CANCER CONTROL OUTCOMES AT 5 YEARS OF FOCAL THERAPY (USING HIFU & CRYOTHERAPY) TO RADICAL PROSTATECTOMY FOR CLINICALLY SIGNIFICANT NON-METASTATIC PROSTATE CANCER: PROPENSITY SCORE-MATCHED ANALYSIS
26. MP78-12 ROBOTIC ASSISTED RADICAL PROSTATECTOMY AFTER FOCAL THERAPY: ONCOLOGICAL AND FUNCTIONAL OUTCOMES
27. MP78-14 SITE OF DISEASE RECURRENCE FOLLOWING PROSTATE FOCAL THERAPY PREDICTS ONCOLOGICAL OUTCOME AFTER SALVAGE ROBOTIC ASSISTED RADICAL PROSTATECTOMY
28. MP78-05 MEDIUM TERM ONCOLOGICAL OUTCOMES IN A LARGE COHORT OF MEN TREATED WITH EITHER FOCAL- OR HEMI-ABALTION WITH HIFU FOR PRIMARY LOCALIZED PROSTATE CANCER
29. Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial
30. Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study
31. Re: Effect of Prior Focal Therapy on Perioperative, Oncologic and Functional Outcomes of Salvage Robotic Assisted Radical Prostatectomy
32. MP16-15 T-STAGE MIGRATION WITH ROUTINE MRI STAGING MAY IMPACT ON RISK ASSESSMENT WITH CURRENT RISK CALCULATORS
33. PD34-07 PSA FAILS TO PREDICT TREATMENT FAILURE IN FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND THERAPY IN PROSTATE CANCER
34. MP30-05 PROSTATE RADIOFREQUENCY ABLATION FOCAL TREATMENT (PRORAFT): RESULTS OF A PROSPECTIVE DEVELOPMENT STUDY FOR LOCALISED PROSTATE CANCER
35. PD34-08 DETERMINANTS OF ERECTILE DYSFUNCTION FOLLOWING FOCAL ABLATIVE THERAPY FOR LOCALISED PROSTATE CANCER.
36. MP30-10 HIFU DOSE ESCALATION LEADS TO FEWER RECURRENCES IN FOLLOWING FOCAL HIFU IN PROSTATE CANCER
37. PD60-11 DISTINCT PROTEIN EXPRESSION PATTERNS FOR COMMON BIOMARKERS IN MALIGNANT AND ADJACENT BENIGN PROSTATE TISSUE: AN IMMUNOHISTOCHEMICAL STUDY ON NEEDLE BIOPSY MICROARRAYS DERIVED FROM AN IMAGING-BASED PATIENT COHORT
38. MP30-11 PREDICTORS OF POOR FUNCTIONAL OUTCOMES AFTER FOCAL HIGH INTENSITY FOCUSSED ULTRASOUND (HIFU)
39. PD60-02 DISCOVERY AND VALIDATION OF A NOVEL FLUID BIOMARKER FOR THE DIAGNOSIS AND RISK STRATIFICATION OF PROSTATE CANCER
40. MP70-02 CORRELATION OF MPMRI CONTOURS WITH 3-DIMENSIONAL 5MM TRANSPERINEAL PROSTATE MAPPING BIOPSY WITHIN THE PROMIS TRIAL PILOT: WHAT MARGINS ARE REQUIRED?
41. MP70-18 PROSTATE RADIOFREQUENCY ABLATION FOCAL TREATMENT (PRORAFT): INTERIM RESULTS OF A PROSPECTIVE DEVELOPMENT STUDY
42. MP38-07 SHOULD WE AIM FOR THE CENTRE OF AN MRI PROSTATE LESION? CORRELATION BETWEEN MPMRI AND 3-DIMENSIONAL 5MM TRANSPERINEAL PROSTATE MAPPING BIOPSIES FROM THE PROMIS TRIAL
43. The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED—A Randomized, Placebo Controlled, Double-Blind Clinical Trial
44. Nanoknife Electroporation Ablation Trial: A Prospective Development Study Investigating Focal Irreversible Electroporation for Localized Prostate Cancer
45. Editorial Comment
46. Multiparametric ultrasound in the diagnosis of prostate cancer
47. Methodological considerations in assessing the utility of imaging in early prostate cancer
48. A review of economic evaluations of diagnostic strategies using imaging in men at risk of prostate cancer
49. What tumours should we treat with focal therapy based on risk category, grade, size and location?
50. Microstructural Characterization of Normal and Malignant Human Prostate Tissue With Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumours Magnetic Resonance Imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.